Triumeq
"I started this medication within three weeks of diagnosis in September 2015. My initial concerns and scares about side effects quickly turned out to be untrue. Apart from tiredness and join pain in the first few weeks, I have virtually no side effects from the medication. I take it in the evening and aim to have 100% adherence. It is remarkable what science has done in the last 30 years since this condition emerged. One of the drugs in the pill, dolutegravir has a long binding time and so far has had no resistance.I look forward to the results of trials with dolutegravir monotherapy. This would be even better in using only one drug to control the virus. I'd recommend Triumeq to anyone starting treatment or those considering a switch."